The diagnosis of vEDS is established in a proband by identification of a heterozygous pathogenic variant in the alpha-1 gene of type III collagen (<i>COL3A1</i>) by molecular analysis. The gene discussed is PSMA6; the disease is Ehlers-Danlos syndrome, vascular type.